Tone mix
Week by week 52 weeks
Share of Legend Biotech Corporation American Depositary Shares's 148 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Oct 13, 2025 · tone -99FDA Warns of Risks on J&J, Legend Biotech Cancer Therapy Label-146
- Week of Nov 17, 2025 · tone -100Royal Bank Of Canada Cuts Legend Biotech (NASDAQ:LEGN) Price Target to $74.00-126
- Week of Aug 17, 2026 · tone -100Royal Bank Of Canada Cuts Legend Biotech (NASDAQ:LEGN) Price Target to $58.00-125
- Week of Apr 6, 2026 · tone +100Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Given Average Recommendation of "Moderate Buy" by Brokerages+87
- Week of Apr 27, 2026 · tone +100H.C. Wainwright Reaffirms Buy Rating for Legend Biotech (LEGN)+82
- Week of Oct 20, 2025 · tone +100J.P. Morgan Maintains a Buy on Legend Biotech Corporation (LEGN)+75
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Legend Biotech Corporation American Depositary Shares in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 0 | No headlines |
| Last 30 sessions | 11 | +45 |
| Last 90 sessions | 37 | +31 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Friday, October 16, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.rttnews.com · 1 outletLegend Biotech Wins FDA Clearance For In Vivo CAR-T Therapy LB2501; Stock UpPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Legend Biotech Wins FDA Clearance For In Vivo CAR-T Therapy LB2501; Stock Up | www.rttnews.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 15, 2026
2 headlines, average tone +100: 2 positive, 0 neutral and 0 negative. Showing all 2.
- www.themarketsdaily.com · 1 outletHC Wainwright Boosts Earnings Estimates for Legend BiotechPositive
- www.manilatimes.net · 1 outletLegend Biotech Announces U.S. FDA Clearance of IND Application for LB2501, an Investigational CD19/CD20 In Vivo CAR-T TherapyPositive
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| HC Wainwright Boosts Earnings Estimates for Legend Biotech | www.themarketsdaily.com | 1 | Positive |
| Legend Biotech Announces U.S. FDA Clearance of IND Application for LB2501, an Investigational CD19/CD20 In Vivo CAR-T Therapy | www.manilatimes.net | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 13, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.tickerreport.com · 1 outletContrasting Legend Biotech (NASDAQ:LEGN) & Connect Biopharma (NASDAQ:CNTB)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Contrasting Legend Biotech (NASDAQ:LEGN) & Connect Biopharma (NASDAQ:CNTB) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 12, 2026
1 headline, average tone -100: 0 positive, 0 neutral and 1 negative. Showing all 1.
- www.tickerreport.com · 1 outletLegend Biotech (NASDAQ:LEGN) Stock Gets Price Target Cut from Royal Bank Of CanadaNegative
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Legend Biotech (NASDAQ:LEGN) Stock Gets Price Target Cut from Royal Bank Of Canada | www.tickerreport.com | 1 | Negative |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 7, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletFinancial Analysis: Q32 Bio (NASDAQ:QTTB) versus Legend Biotech (NASDAQ:LEGN)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Financial Analysis: Q32 Bio (NASDAQ:QTTB) versus Legend Biotech (NASDAQ:LEGN) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Legend Biotech Corporation American Depositary Shares, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.